Borchmann P, Goergen H, Kobe C, et al. Treatment reduction in patients with advanced-stage Hodgkin lymphoma and negative interim PET: final results of the international, randomized phase 3 trial HD18 by the German Hodgkin Study Group. EHA 2017, abstract S150.
Isatuximab in combinatie met pomalidomide en dexamethason bij recidief/refractair MM
mrt 2020 | MM